Long-term study links common IBS medications to higher mortality
US 17 avr. 2026Signal de tendance
4
mentions (7j)
4
mentions (30j)
17 avr. 2026
premier signal
1
pays concernés
Contexte et analyse
Cette tendance "Long-term study links common IBS medications to higher mortality" a été détectée dans la catégorie Santé & Médecine avec un score de 100/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.
Entités liées
Extraits des sources
Science News from research organizations * * * Date:April 16, 2026 Source:Cedars-Sinai Medical Center Summary:A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some widely used medications—including antidepressants and certain antidiarrheal drugs—were linked to a small but noticeable increase in the risk of death over time.Share: FULL STORY * * * ! A large...
— sciencedaily.com
Ce que disent les sources
"A nearly 20-year study of over 650,000 Americans with IBS found associations between certain antidepressants and antidiarrheal drugs and a small but increased risk of death."
"Research indicates that antidepressant use in IBS is linked to a 35% higher risk of all-cause mortality, highlighting safety issues with long-term..."
"Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person's risk of early death. However, the risk is relatively..."
"Several of the most common treatments for irritable bowel syndrome could raise the risk of death, a study from researchers at Cedars-Sinai Health Sciences..."